Clenbuterol is a direct-acting sympathomimetic agent and is used as a bronchodilator in the management of asthma and obstructive lung disease.
It has a considerably longer half-life than other sympathomimetic asthma preparations such as salbutamol. Clenbuterol has been used illicitly in cattle feeds in an attempt to promote weight gain and to increase muscle to lipid mass. Adverse effects typical of sympathomimetic activity have been attributed to such misuse both in farmers in contact with affected cattle and in persons consuming meat products from affected animals. Clenbuterol has become popular as a performance-enhancing drug because of its anabolic/anticatabolic effects. It is also commonly recognized as a fat-burning agent, as it increases the body temperature. Clenbuterol hydrochloride does not have a pharmaceutical licence for use in the UK, but is relatively easily available.
The regime of oral administration varies considerably and is dependent on body weight, body temperature, the desired effect and the commonly held belief of rapid receptor downgrade. The most commonly reported side-effects include nervousness, anxiety, tremors, palpitations, tachycardia, headaches and insomnia. These side-effects are commonly considered to be dose related and temporary.
About SP Laboratories
SP Laboratories is an organization that is manufacturing drugs under the contract for pharmaceutical companies, a project plant that is producing and making clinical tests into humans for adverse side effects and sure effects.
SP Laboratories is manufacturing production tests, pilot lots of drugs for pharmaceutical companies.
Specifically, SP Laboratories provide support services covering the spectrum of pharmaceutical companies manufacturing functions, from commercial production to all necessary documents for legal approval, but can t guarantee that the formulations will be approved. It is only manufacturing the formulations under the contract that the pharmaceutical companies are asking for.
SP Laboratories is working to meet the diverse needs of such pharmaceutical companies through the provision of flexible and expeditious services, producing under the contract, at customer request.